kabutan

OncoTherapy Science, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.

Fri May 8, 2026 5:00 pm JST Earnings

4564 OncoTherapy Science, Inc. 【J-GAAP】

Earnings Report

OncoTherapy Science, Inc. <4564> [TSE Growth] announced its financial results after the market closed on May 8th (17:00). The consolidated net loss for the fiscal year ended March 2026 expanded to a loss of 910 million yen (compared to a loss of 815 million yen in the previous period). This marks the fourteenth consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending March 2027.

In the most recent three-month period, from January to March (4Q), the consolidated net loss expanded to a loss of 127 million yen (compared to a loss of 98 million yen in the same period last year). The operating profit/loss margin worsened from -52.9% in the same period last year to -55.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 610 -1,120 -1,136 -1,288 -6.1 0 May 10, 2024 J-GAAP
Mar, 2025 750 -797 -815 -815 -3.1 0 May 9, 2025 J-GAAP
Mar, 2026 808 -810 -845 -910 -2.8 0 May 8, 2026 J-GAAP
YoY +7.7% -1.6% -3.7% -11.7% +11.2%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance ー ー ー ー － 0 May 9, 2025 J-GAAP
Mar, 2026 Results 808 -810 -845 -910 -2.8 0 May 8, 2026 J-GAAP
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 431 -475 -493 -555 -1.9 － Nov 7, 2025 J-GAAP
Apr - Sep, 2026 Guidance ー ー ー ー － － May 8, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 750 -797 -815 -815 -3.1 0 May 9, 2025 J-GAAP
Mar, 2026 808 -810 -845 -910 -2.8 0 May 8, 2026 J-GAAP
Mar, 2027 Guidance ー ー ー ー － 0 May 8, 2026 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 187 -99 -99 -98 -0.4 -52.9 May 9, 2025 J-GAAP
Apr - Jun, 2025 201 -303 -313 -314 -1.1 -150.7 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 230 -172 -180 -241 -0.8 -74.8 Nov 7, 2025 J-GAAP
Oct - Dec, 2025 166 -219 -227 -228 -0.7 -131.9 Feb 6, 2026 J-GAAP
Jan - Mar, 2026 211 -116 -125 -127 -0.4 -55.0 May 8, 2026 J-GAAP
YoY +12.8% -17.2% -26.3% -29.6% -2.6%

Related Articles